|
|
Shanghai Haohai Biological Technology Co Ltd
HKSE •
Healthcare •
Biotechnology •
Quote as of 06/12/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization4,099.21 mln
Float85.61 mln
Earnings Date08/21/2026
Relative Strength
20
/ 100
Significantly lagging
Key Fundamentals
EPS1.25
P/E13.06
ROE2.07
RPS8.33
ROIC3.50
ROA1.65
Interest Cover11.44
EBITDA, mln358
EV / EBITDA16.22
EV / EBIT44.90
Revenue, mln1,916
EV / Revenue3.03
Financial Strength
Altman Z-Score5.25
Piotroski F-Score
4
/ 9
Beneish M-Score-2.38
Price to Intrinsic Value0.96
Price to Lynch Fair Value3.42
Price to Graham Number1.22
Shiller PE Ratio10.78
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-8.38% |
14
/ 100
 |
| 1 Month |
-26.13% |
9
/ 100
 |
| 2 Months |
-32.79% |
14
/ 100
|
| 6 Months |
-40.79% |
13
/ 100
|
| 1 Year |
-32.84% |
19
/ 100
 |
|
| |
